Ondine Biomedical Inc.
OBIMF
$0.11
-$0.02-15.39%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.47% | -20.28% | 1.41% | 17.44% | -0.68% |
| Total Depreciation and Amortization | -1.42% | 1.64% | -1.43% | -7.40% | 0.71% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.51% | 923.08% | 1.17% | -108.90% | 0.73% |
| Change in Net Operating Assets | -1.43% | -97.61% | -1.41% | 172.89% | -0.69% |
| Cash from Operations | 1.47% | -30.47% | 1.41% | 32.87% | -0.68% |
| Capital Expenditure | 0.00% | -236.36% | 0.00% | 98.30% | -0.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00% | -236.36% | 0.00% | 98.30% | -0.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -3.70% | 0.00% | -2.37% | 0.00% |
| Issuance of Common Stock | 0.00% | 23.35% | 0.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 21.43% | 0.00% | -- | -- |
| Cash from Financing | -1.47% | 33.46% | -1.41% | 1,997.58% | -0.64% |
| Foreign Exchange rate Adjustments | -1.32% | 8.57% | -1.41% | 130.02% | -0.85% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.48% | -23.21% | 1.41% | 83.30% | -0.69% |
